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Abstract
Connexin36 (Cx36), a trans-membrane protein that forms gap junctions between insulin-secreting beta-cells in the
Langerhans islets, contributes to the proper control of insulin secretion and beta-cell survival. Hypercholesterolemia and
pro-atherogenic low density lipoproteins (LDL) contribute to beta-cell dysfunction and apoptosis in the context of Type 2
diabetes. We investigated the impact of LDL-cholesterol on Cx36 levels in beta-cells. As compared to WT mice, the Cx36
content was reduced in islets from hypercholesterolemic ApoE2/2 mice. Prolonged exposure to human native (nLDL) or
oxidized LDL (oxLDL) particles decreased the expression of Cx36 in insulin secreting cell-lines and isolated rodent islets.
Cx36 down-regulation was associated with overexpression of the inducible cAMP early repressor (ICER-1) and the selective
disruption of ICER-1 prevented the effects of oxLDL on Cx36 expression. Oil red O staining and Plin1 expression levels
suggested that oxLDL were less stored as neutral lipid droplets than nLDL in INS-1E cells. The lipid beta-oxidation inhibitor
etomoxir enhanced oxLDL-induced apoptosis whereas the ceramide synthesis inhibitor myriocin partially protected INS-1E
cells, suggesting that oxLDL toxicity was due to impaired metabolism of the lipids. ICER-1 and Cx36 expressions were closely
correlated with oxLDL toxicity. Cx36 knock-down in INS-1E cells or knock-out in primary islets sensitized beta-cells to oxLDL-
induced apoptosis. In contrast, overexpression of Cx36 partially protected INS-1E cells against apoptosis. These data
demonstrate that the reduction of Cx36 content in beta-cells by oxLDL particles is mediated by ICER-1 and contributes to
oxLDL-induced beta-cell apoptosis.
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Introduction
Type 2 diabetes (T2D) originate from abnormalities in both
glucose and lipid metabolism leading to b-cell failure to
compensate insulino-resistance and adequately secrete the insulin
necessary to maintain glucose and lipid homeostasis [1,2].
The fine-tuning of insulin secretion in response to nutrient
stimulation relies on a closely coordinated functioning of
pancreatic b-cells. The importance of cell-to-cell communication
mediated by gap junction channels in that process is often
undervalued. In b-cells, gap junctions made solely of connexin36
(Cx36) contribute to synchronization of clusters, which appears
essential to maintain b-cell function [3,4,5,6] and survival [7]. We
further demonstrated that long-term exposure to high concentra-
tion of glucose or saturated free fatty acids (FFAs), alone and in
combination, result in a reduced expression of Cx36 in insulin-
secreting cells [4,8]. Given its key role in b-cell function and
survival, Cx36 down-regulation might thus contribute to b-cell
failure in relation to glucolipotoxicity.
Beside increased levels of circulating FFAs, the dyslipidemia
associated with T2D is characterized by low plasma levels of High
Density Lipoproteins (HDL), together with increased levels of
modified atherogenic oxidized LDL-cholesterol (oxLDL)
[9,10,11,12,13]. Alterations of these lipoproteins levels precede
the development of diabetes and may therefore contribute to the
progression of the disease [11,14,15]. Prolonged exposure of
insulin-producing cell lines as well as isolated human and rodents
islets to oxLDL particles at physiological cholesterol concentration
compromises insulin production and secretion and eventually
leads to b-cell apoptosis [16,17,18,19]. On the other hand, HDL
particles have been shown to protect the cells against harmful
effects of pro-apoptotic stressors including oxLDL [20,21]. Given
its role in b-cell survival, the purpose of this study was to determine
the involvement of Cx36 in the pro-apoptotic effect of oxLDL
particles on b-cells. We first evaluated the impact of prolonged
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hypercholesterolemia on Cx36 expression in vivo using the
hypercholesterolemic, pro-atherogenic ApoE deficient mouse
(ApoE2/2) [22,23,24] and observed that the Cx36 levels were
decreased in ApoE2/2 compared to WT mice. We next studied
the effect of isolated human lipoprotein particles on Cx36
expression in b-cells in vitro and demonstrated that prolonged
exposure to oxLDL but not native LDL (nLDL) particles down-
regulated Cx36 expression through a transcriptional mechanism
involving the overexpression of the inducible early repressor 1
(ICER-1). We further showed that Cx36 knock-down in INS-1E
cells sensitized b-cells to oxLDL-induced apoptosis and extended
this observation in primary islets using Cx36 KO (2/2) mice. In
contrast, Cx36 overexpression partially protected INS-1E cells
from the pro-apoptotic effect of oxLDL particles.
Materials and Methods
Lipoprotein Preparation
Blood was collected from healthy donors. Plasma LDL fractions
were isolated by sequential ultracentrifugation (LDL density,
1.063) and dialyzed against PBS. Samples were analyzed by SDS-
PAGE to assess the integrity of apolipoproteins and the purity of
the different fractions. The lipoprotein preparations contained less
than 0.112 unit of endotoxin/mmol of cholesterol as determined by
the kinetic chromogenic technique (Endotell, Allschwil, Switzer-
land). Oxidation of LDL particles was performed by incubation of
1 mg LDL protein/ml PBS with 5 mM CuSO4 at 37uC for 6–8 h.
The oxidation reaction was stopped at 4uC for 30 min by adding
300 mM EDTA. The oxidized as well as native LDL particles were
dialysed against PBS and subsequently against either DMEM or
RPMI medium without foetal calf serum. The oxidation reaction
was verified by determining the lipid peroxide content as
previously described [19].
Cell Culture
The rat insulinoma cell line INS-1E (kindly provided by Dr.
Pierre Maechler, CMU, University of Geneva [25]) was main-
tained in the complete RPMI 1640 medium as previously
described [25]. MIN6-B1 (kindly provided by Dr. Philippe.
Halban, CMU, University of Geneva [26]) were cultured in
DMEM as previously described [26].
Oil Red O Staining
Oil red O (Solvent Red 27 or Sudan Red 5B) was used to stain
endogenous lipid deposits. INS-1E cells grown or glass coverslips
were fixed for 30 min in 3.7% paraformaldehyde. After washing,
fixed cells were incubated for 20 min in oil red O (Sigma-Aldrich)
staining solution (0.5% in isopropanol), and counter-stained lightly
by dipping the coverslips in an hematoxyline solution [27].
Mouse Models and Langerhans Islets Preparation
Rat or mouse islets of Langerhans were isolated from the
pancreas by collagenase digestion, filtered on a 100 mM cell
strainer (BD Biosciences), hand-picked under a stereomicroscope
and cultured as previously described [4,7,28]. WT or ApoE2/24
months old male C57BL6 mice were generated, housed and cared
for as previously described [23,29]. Blood samples for plasma
analyses were taken by heart puncture. Concentrations of glucose
and lipids were measured in the plasma of mice sacrified while in
a fed state. Measurements were conducted at The Mouse
Metabolic Evaluation Platform facility from the Universty of
Lausanne (http://www.cardiomet.ch/en/cmet_home/cardiomet-
chercheurs/cardiomet-chercheurs-plateforme_metabolique.htm).
The Cx362/2 mice were generated, housed and cared for as
previously described [7,28].
Western Blot Analyses
Cells were washed once with cold PBS and directly lysed with
Laemmli buffer. Nuclear extracts for ICER-1, ICER-1c and
CREM immunoblots were prepared as previously described [4].
Lysates were then resolved by SDS-PAGE and transferred to
a PVDF membrane. Immunoblot analyses were performed as
previously described [4,30] using the following antibodies: Rabbit
polyclonal antibodies against Cx36 [4,8], monoclonal anti a-
tubulin antibodies (Fluka Chemie, diluted 1:2,000); rabbit poly-
clonal anti CREM-1 sc440 (Santa Cruz, 1:500). After incubation
at room temperature (1 h) with the appropriate secondary
antibody conjugated to horseradish peroxidase (Fluka Chemie,
diluted 1:20,000), membranes were revealed by enhanced
chemiluminescence (immobilon, millipore) using the Chemi-
DocTM XRS+ System and analyzed using the accompanying
proprietary program Image Lab (BETA2) version 3.0.01(Bio-Rad
Laboratories, Reinach, Switzerland ).
RNA Isolation, and Quantitative RT-PCR (Lightcycler)
Cells were homogenized in the Tripure Isolation Reagent
(Roche Diagnostics) and total RNA was extracted using the kit
procedure. mRNA from freshly isolated mouse islets were isolated
using nucleospin RNA II columns (Macherey-Nagel). Transcripts
(1 mg) were reverse-transcribed using ImProm-2 Reverse tran-
scription System (Promega). Quantitative PCR was performed
using the SYBRH Premix ExTaqTM (Takara) in a Lightcycler
Instrument (Roche Diagnostics). cDNAs were amplified using the
following primers: rat Cx36: 59-ATACAGGTGTGAATGAGG-
GAGGATG-39 (sense); 59- TGGAGGGTGTTACAGATGAAA-
GAGG-39 (antisense). Rat ribosomal protein L-27 59-GATC-
CAAGATCAAGTCCTTTGTG-39 (sense); 59-
CTGGGTCTCTGAACACATCCT-39(antisense). Rat ICER-1:
59-CTGGGTCTCTGAACACATCCT-39 (sense) 59-
CACCTTGTGGCAAAGCAGTA-39(antisense). Rat Plin 9-
GCTTCTCTCCCCAAGGAAAC-39 (sense); 59-
TGCCCCTTAAAACCTGACTG-39 (antisense). Rat ACC1 59-
CAGGTTCAGAGCGAGAGATG-39 (sense); 59-AT-
GATGGCTCGGATGAAGAA-39 (antisense). Rat SOD1:59-
TTCCATCATTGGCCGTA-39 (sense); Rat SOD1: 59-
AAGCGGCTTCCAGCATTTC-39 (antisense). Rat-SOD2: 59-
TGGTGTGAGCTGCTCTTGATTG-39 (sense); Rat SOD2: 59-
GCCCCAACACAGAGATGGAATA-39 (antisense).
Transient Transfection and Luciferase Assays
INS-1E cells were co-transfected using lipofectamine 2000
(Invitrogen, Baesley, UK) with the internal control pRL-CMV
encoding Renilla luciferase (Promega, Madison, WI, USA),
various reporter plasmids containing the luciferase gene under
control of different fragments of the human Cx36 promoter,
together with an empty vector (pCDNA3), or a plasmid allowing
constitutive expression of ICER-1 [31] or an ICER antisense
plasmid [32], as previously described [4,8]. 24 hours after
transfection, the cells were incubated in presence or absence of
2 mM (78 mg/dl) nLDL or oxLDL particles. Sample preparation,
luciferase activities and values correction were performed as
previously described [4,8].
Rat Cx36 SilencerH Select pre-designed siRNA s132237
(siRNA#1) and s132238 (siRNA#2) were from Applied Biosys-
tems (Life Technologies Corporation, Carlsbad, California,
U.S.A). The Allstars Negative Control siRNA (Qiagen, Hom-
brechtikon, Switzerland), which has no effect on b-cell gene
oxLDL Down-Regulate Cx36 Expression
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expression and viability, was used as a control [30,33,34]. siRNA
transfections were conducted as previously described using
lipofectamin RNAiMax (Invitrogen) with a final concentration of
30 nM siRNA. The efficiency of transfection is .90% [30,33,34].
siRNA transfections under these conditions do not affect b-cell
function [30,34]. Cells were then cultured for a 48-hour recovery
period before being collected or treated as indicated.
ROS/RNS Superoxide Measurements
TheROS/RNS and superoxide productionweremeasured using
the total ROS/Superoxide Detection Kit (Enzo Life Sciences AG,
Lausen, Switzerland). Briefly, INS-1E cells were plated in 96 well
plates. Following a 48 h treatment with lipoproteins, cells were
washed once and incubated for 30 min in 100 ml of wash buffer
containing 2 mM of oxidative stress detection reagent (green) and
2 mM of superoxide detection reagent (orange). Fluorescence was
quantified using a fluorescence microplate reader and standard
fluorescein (Ex= 488 nm, Em=520 nm) and rhodamine
(Ex= 550 nm, Em=610 nm) filter sets.
Generation of Recombinant Adenoviruses and Cell
Infection
Control adenovirus encoding GFP (Ad-GFP) was generated as
previously described [35]. The adenovirus encoding rat Cx36 (Ad-
Cx36) was generated by Vector Biolabs, Philadelphia, PA, U.S.A.
using rat the complete rat Cx36 coding sequence (GenBank:
AJ296282.1) cloned using the TA cloning system pGEM-Teasy
(Promega). Infection was performed as previously described [5,30].
Assessment of Cell Viability
The percentage of viable, apoptotic and necrotic cells was
determined using the DNA-binding dyes Propidium Iodide (PI,
5 mg/ml) and Hoechst 33342 (HO, 5 mg/ml, Sigma-Aldrich) [36].
The cells were examined by inverted fluorescence microscopy
(Axiovert 200, Carl Zeiss, Zaventem, Belgium). A minimum of 500
cells was counted in each experimental condition by two
independent observers, one of them unaware of sample identity.
Total islet viability was evaluated by two independent observers,
both of them unaware of sample identity. At least 20 islets per
condition were counted, as previously described [37].
Statistical Analysis
Data are presented as means 6 SEM. Comparisons were
performed by two-tailed paired Student’s t-test or by one-way
ANOVA followed by t-tests with Bonferroni correction for
multiple comparisons. Non-parametric x2 tests were further used
to assess differences between non-Gaussian distributions. A p value
#0.05 was considered statistically significant.
Ethics Statement
Mouse care, surgery and euthanasia procedures were approved
by our institution and the Cantonal Veterinary Office (Service de
la Consommation et des Affaires Ve´te´rinaires SCAV-EXPANIM).
Written, informed consent was obtained from all blood donors.
The study protocols for blood collection and lipoproteins
preparation were reviewed and approved by the clinical research
ethics committee of the Centre Hospitalier Universitaire Vaudois
(CHUV).
Results
To assess whether cholesterol participates in vivo to the control
of Cx36 expression, we characterized the expression of Cx36 in
ApoE2/2 C57BL6 male mice. As compared to WT mice,
ApoE2/2 mice displayed an 8 fold increase in total circulating
levels of cholesterol and a 70 fold increase in LDL levels (Table 1).
In addition there was also a 3 fold increase in triglycerides and a 2
fold increase in circulating FFA, whereas the glycemia remained
normal and similar in both groups (Table 1). As compared to
WT mice, Cx36 mRNA levels were significantly decreased in
ApoE2/2 mice, and there was a trend toward an increase in
ICER-1 mRNA level (P = 0,057; Figure 1A). Moreover, quanti-
tative assessment of Cx36 immunofluorescent labeling on frozen
pancreas sections (see Methods S1) from WT or ApoE2/2 mice
revealed a significantly decreased Cx36 punctate staining in
ApoE2/2 compared to WT mice (Figure S1).
We then investigated the in vitro effects of human native (nLDL)
or oxidized LDL (oxLDL) on Cx36 expression in insulin-secreting
cell lines and primary rat islets. Cx36 mRNA levels were decreased
by 50% in INS1-E cells, MIN-6B1 cells and primary rat islets
cultivated for 72 hours in medium supplemented with 2 mM
(78 mg/dl) of human oxLDL particles, but not nLDL (Figure 1B).
Time course analysis revealed that Cx36 mRNA expression was
already significantly reduced after 48 h of culture in presence of
oxLDL (Figure 1C). Subsequent experiments were performed after
48 h of exposure to lipoproteins. At the protein level, Cx36
expression was decreased in both INS-1E cells (Figure 1D) and
primary isolated islets (Figure 1E) exposed for 48 h to 2 mM
oxLDL, but not nLDL.
We previously showed that Cx36 expression is controlled by the
cAMP/PKA pathway [4,8]. INS-1E cells were exposed to nLDL
or oxLDL for 48 h, in presence of the cAMP dependent protein
kinase A (PKA) inhibitor H89 (10 mM). As shown in Figure 2A,
H89 prevented the Cx36 decrease elicited by oxLDL, suggesting
that the cAMP/PKA pathway mediates the oxLDL effect on Cx36
expression. We recently established that ICER-1 is overexpressed
after prolonged exposure to oxidized, but not native, LDL
particles [19]. Here, we confirmed that oxLDL, but not nLDL
particles, induced a two to three fold increase in ICER-1 mRNA
levels in INS-1E cells, MIN-6 cells and isolated rat islets
(Figure 2B). Time course analysis further revealed that ICER-1
mRNA expression is already significantly upregulated after 24 h of
culture in presence of oxLDL (Figure 2C). Using an antibody
directed against CREM-1 (cAMP response element modulator)
that detected ICER-1 and ICER-1c, the two major repressive
isoforms of CREM expressed in b-cells, we further confirmed that
a 48 h exposure to oxLDL particle, but not nLDL particles,
increased ICER-1 and ICER-1c protein levels in nuclear extracts
from INS-1E cells (Figure 2D). In addition, the oxLDL-driven
ICER-1 overexpression was PKA-dependent as H89 inhibited
ICER-1 overexpression in nuclear extracts from INS-1E cells
(Figure 2D).
We have previously demonstrated that ICER-1 binds to a highly
conserved CRE (cAMP response element) located between bases
2566 and 2556 upstream of the transcription start site of the
Cx36 gene [4,8]. To assess the involvement of this CRE in the
oxLDL-induced Cx36 downregulation, a plasmid expressing the
reporter gene luciferase under the control of a fragment of the
human CX36 promoter containing the CRE (pGL3-1079) was
transiently transfected in INS-1E cells incubated in presence of
2 mM LDL, native or oxidized, for 24 hours. oxLDL induced
a 40% decrease in the luciferase activity driven by the CX36
promoter fragment (Figure 3A). In contrast, oxLDL did not reduce
the activity of a similar plasmid containing a mutated CX36 CRE
(pGL3-1079m). To investigate the involvement of ICER-1 in the
control of the CX36 gene expression, INS-1E cells were
cotransfected with either an empty vector (pCDNA3) or an
oxLDL Down-Regulate Cx36 Expression
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antisense ICER construct (ICER AS) reducing the endogenous
ICER-1 and ICER-1c content [4,32]. ICER AS fully blocked the
effect of oxLDL on the CX36 promoter activity, indicating that
ICER-1 drove the oxLDL effect on Cx36 expression. Further-
more, blocking ICER-1 overexpression using ICER AS prevented
oxLDL-induced down-regulation of endogenous Cx36 protein
(Figure 3B).
We recently demonstrated that Cx36 plays a protective role in
cytokine-induced b-cell apoptosis [7] and prolonged exposure to
oxLDL induces b-cell apoptosis [17,19]. Here, we observed that
a 48 h exposure to 2 mM oxLDL induced 15 to 20% apoptosis in
INS-1E cells and we confirmed that 1 mM (40 mg/dl) HDL
particles protected b-cells from oxLDL-mediated apoptosis [17,18]
(Figure 4A). HDL particles also prevented the oxLDL-induced
Cx36 protein downregulation (Figure 4B), indicating that there is
a correlation between the decreased levels of Cx36 and oxLDL-
induced apoptosis.
Lipid toxicity in b-cells is thought to be mostly due to
accumulation of free fatty acyl CoA levels entering non-oxidative
toxic pathways of fatty acids metabolism, such as de novo
ceramide formation which trigger reactive oxygen species (ROS)
production [38]. This may be caused both by a defect in lipid
storage in the form of neutral lipid droplets, or through a defect in
lipid b-oxidation in the mitochondria. We monitored the
formation of lipid droplets after a 24 h exposure to 2 mM nLDL
or oxLDL particles in INS-1E cells. In control condition, rare
Figure 1. Prolonged exposure to oxidized LDL particles decreases Cx36 levels in b-cells. A) Langerhans islets were isolated from adult
male WT or ApoE2/2 C57Bl6 mice and immediatly sampled for mRNA extractions. Cx36 and ICER-1c mRNA levels were analyzed by quantitative RT-
PCR, and normalized to the expression of the housekeeping gene L27. Results are means6 SEM of six animals in each group. B) INS-1E cells, MIN6-B1
cells, or primary rat islets were cultured for 72 h in presence or absence (Vh for Vehicule) of 2 mM native (nLDL) or oxidized LDL (oxLDL). Quantitative
RT-PCR of Cx36 mRNA levels normalized to the levels of the housekeeping gene L27. Data represent mean 6 SEM of four to six independent
experiments. *P,0.05; **P,0.01 vs. control. C) Time course analysis of Cx36 mRNA levels in INS-1E cells cultured in absence (Vh for Vehicule) or
presence of 2 mM native (nLDL) or oxidized LDL (oxLDL). Data are mean 6 SEM of four independent experiments. *P,0.05; **P,0.01 vs control
condition (vehicle treated). D–E)Western blot analyses of Cx36 levels in INS-1E cells (D) or primary isolated rat islets (E) cultured for 48 h in presence or
absence (Vh for Vehicule) of 2 mM native (nLDL) or oxidized LDL (oxLDL). (D) Data are mean 6 SEM of five independent experiments. (E) Blot shows
three independent experiments.
doi:10.1371/journal.pone.0055198.g001
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small regular lipid droplets were detected whereas abundant big
regular lipid droplets were observed in presence of nLDL. In
contrast, in presence of oxLDL, the lipid droplets were smaller and
less abundant, suggesting that oxLDL were not stored in lipid
droplets to the same extend as nLDL (Figure 5A). Exposure to
nLDL also stimulated the expression of the perilipin 1 (Plin1)
transcripts, a marker of lipid droplets, whereas oxLDL treatment
did not significantly increase Plin1 mRNA expression as compared
to vehicle-treated INS-1E cells (Figure 5B). We also evaluated the
b-oxidation axis of the LDL particles through the expression of the
Acetyl CoA carboxylase (ACC1) in INS-1E cells exposed to 2 mM
nLDL or oxLDL for 48 h. As compared to control, nLDL induced
a two fold increase in ACC1 mRNA expression, and oxLDL
induced a 1.5 fold increase, suggesting that oxLDL are less
metabolized than nLDL particles (Figure 5B). Inhibition of the
carnitine palmitoyl transferase (CPT1) using etomoxir inhibits the
lipid b-oxidation. In control conditions, a 48 h treatment with
Table 1. Characteristic of WT and ApoE2/2 mice.
WT ApoE2/2
Weight (gr) 25.8260.53 28.960.52*
Glucose (mg/dl) 182.83614.97 206.23616.34
TG (mg/dl) 90.6468.96 316.53628.68***
FFAs (mg/dl) 13.7962.89 27.1863.77*
Total cholesterol (mg/dl) 75.0263.03 316.53638.83***
VLDL/LDL (mg/dl) 4.9060.62 370.51626.27***
HDL(mg/dl) 58.5262.41 109.063.99***
Weight, plasma glucose, triglycrides (TG), free fatty acids (FFAs), total
cholesterol, low density lipoprotein (LDL) and high density lipoproteins (HDL)
levels of adult male WT or ApoE2/2 C57Bl6 mice. Data are means 6 SEM of 8
animals in each group. *P,0.05; ***P,0.001 vs. WT group.
doi:10.1371/journal.pone.0055198.t001
Figure 2. oxLDL overexpress ICER-1 and downregulate Cx36 in a PKA-dependent manner. A)Western Blot analyses of Cx36 over tubulin
levels in INS-1E cells cultured for 48 h in presence or absence (Vh for Vehicule) of 2 mM native (nLDL) or oxidized LDL (oxLDL), together or not with
the PKA inhibitor H89 (10 mM). Upper panel: representative Western blot; lower panel: means 6 SEM of three independent Western blots. ***P,0.01
vs. INS-1E control. #P,0.05 vs. oxLDL condition in absence of H89. B) Quantitative RT-PCR of ICER-1 over L27 mRNA expression in INS-1E cells, MIN6-
B1 cells, or primary rat islets cultured for 72 h in presence or absence (Vh for Vehicule) of 2 mM native (nLDL) or oxidized LDL (oxLDL). Data represent
mean 6 SEM of four to six independent experiments. C) Time course analysis of ICER-1 mRNA levels in INS-1E cells cultured in presence of oxLDL.
*P,0.05; **P,0.01 vs control condition (vehicle treated). D) Western Blot analyses of ICER-1 and ICER-1c levels in INS-1E cells cultured for 48 h in
presence or absence (Vh for Vehicule) of 2 mM native (nLDL) or oxidized LDL (oxLDL), together or not with the PKA inhibitor H89. Upper panel:
representative Western blot; lower panel: Results are means 6 SEM of three independent Western blots. ***P,0.01 vs. INS-1E control.
doi:10.1371/journal.pone.0055198.g002
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etomoxir (50 mM) had no impact on INS-1E cells viability
(Figure 6A). In contrast, in presence of 2 mM nLDL or oxLDL,
etomoxir significantly increased INS-1E cell apoptosis, suggesting
that lipid metabolism may protect INS-1E cells against LDL
toxicity (Figure 6A). On the contrary, the antioxidant N-acetyl-
cystein (NAC 1 mM) partially prevented oxLDL-induced apopto-
sis (Figure 6A) as previously reported [19]. We tested the effect of
lipoproteins on the production of reactive oxygen and/or nitrogen
species (ROS/RNS), as well as superoxide anions (O2
2) in living
cells (Figure 6B–C). We observed that oxLDL (2 mM for 48 h),
but not nLDL, stimulated the production of ROS/RNS
(Figure 6B) and superoxide (Figure 6C). As a positive control,
INS-1E cells were treated for 30 min with the ROS inducer
Pyocyanin (200 mM). The antioxidant NAC (1 mM) efficiently
prevented oxLDL-induced production of ROS/RNS. HDL,
which has been shown to prevent oxidative stress in a variety of
models, also significantly reduced oxLDL-induced ROS/RNS
production (Figure 6B). Neither NAC nor HDL blocked oxLDL-
induced generation of superoxide anions (Figure 6C). Etomoxir
had no effect on basal or ox-LDL-induced ROS/RNS and
superoxide production (Figure 6B–C). A 48 h treatment with
oxLDL, but not nLDL, also stimulated the expression of the
cytosolic Cu/Zn-superoxide dismutase (SOD1) (Figure 6D), but
not the mitochondrial Mn-superoxide dismutase (SOD2) (data not
shown). Etomoxir alone had no effect on SOD1 expression but
stimulated SOD1 expression in presence of nLDL. However it did
not exacerbate oxLDL-induced SOD1 overexpression (Figure 6D).
In parallel, etomoxir treatment led to a significant increase in
ICER-1 mRNA levels and enhanced the oxLDL-induced ICER-1
overexpression (Figure 6E). The effect of etomoxir on ICER-1
expression was associated with a decrease in Cx36 mRNA levels
(Figure 6F). Since ceramide pathway has been proposed to play an
important role in lipid toxicity, we tested the effect of the serine
palmitoyltransferase inhibitor myriocin, which blocks ceramide
synthesis, on cell viability and ICER-1 and Cx36 mRNA levels in
INS-1E cells exposed to nLDL or oxLDL particles. Myriocin
treatment (100 nM) had no effect on basal or nLDL-treated cell
apoptosis (Figure 6G). However it significantly reduced oxLDL-
induced apoptosis (Figure 6G). There was also a tendency to
reduce oxLDL-induced ICER-1 overexpression (Figure 6H),
which correlated with partly restored levels of Cx36 mRNA upon
myriocin addition (Figure 6I).
To elucidate the importance of Cx36 down-regulation in
oxLDL-induced apoptosis, INS-1E cells were transiently trans-
fected with two siRNAs directed against rat Cx36 (siCx36 #1 and
#2). Both siRNAs decreased by about 60% Cx36 mRNA (data
not shown) and protein levels (Figure 7A). We next evaluated the
effect of the Cx36 knockdown on b-cell survival. As compared to
cells transfected with a control siRNA (siCtrl), transfection with
Cx36 siRNA#1 or #2 had no effect on basal apoptosis but
rendered nLDL slightly toxic and aggravated apoptosis induced by
a 48 h treatment with oxLDL (Figure 7B). Cx36 knock-down also
aggravated oxLDL-induced ROS/RNS production (Figure 7C)
but had no impact on basal or ox-LDL-induced superoxide
production. To assess the relevance of theses observation in
primary cells, pancreatic islets were extracted from WT (+/+) or
Cx36 knock out (2/2) mice and treated for 72 h with 2 mM
nLDL or oxLDL. Staining of islets with Hoechst-propidium iodine
Figure 3. ICER-1 overexpression mediates the effect of oxLDL on Cx36 expression. A) INS-1E cells were cotransfected with a plasmid
expressing the reporter gene luciferase under the control of a 1 kb fragment of the CX36 promoter, or a fragment containing a mutated CRE,
together with an empty vector (pCDNA3; black bars) or an antisense ICER plasmid (ICER AS; white bars). 24 h post transfection, cells were cultured for
48 h in presence or absence (Vh for Vehicule) of 2 mM nLDL or oxidized LDL oxLDL. Cx36 promoter activity was evaluated by luciferase assay. Data
are mean 6 SEM of five to six experiments. **P,0.01 vs. vehicle-treated cells. B) Western Blot analyses of Cx36 over tubulin levels in INS-1E cells non
transfected (NT), transfected with an empty vector (pCDNA3) or the antisense ICER plasmid (ICER AS) and treated with native LDL (nLDL) or two
different preparations of oxidized LDL (oxLDL1 or 2). Data are representative of three independent experiments.
doi:10.1371/journal.pone.0055198.g003
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revealed that nLDL and, to a greater extend oxLDL particles,
significantly reduced islets viability in WT and Cx362/2 islets
(Figure 7D). As compared to WT(+/+) islets, Cx362/2 islets were
sensitized to nLDL or oxLDL toxicity (see Table S1 for individual
values and statistical analyses). To test whether Cx36 protects b-
cell against oxLDL, INS-1E cells were infected with an adenovirus
overexpressing rat Cx36 (Ad-Cx36) [5]. As compared to non-
infected (NI) cells or cells infected with the control virus encoding
GFP (Ad-GFP), Ad-Cx36-infected INS-1E cells displayed dose-
dependently increased levels of Cx36 (Figure 7E upper panel). We
next evaluated the effect of Cx36 overexpression on b-cell survival.
As compared to non-infected (NI) or Ad-GFP-infected cells, Ad-
Cx36-infected INS-1E cells displayed a 30% reduction in
apoptosis following exposure to oxLDL particles (Figure 7E lower
panel).
Discussion
Obesity and more particularly, high levels of low density
lipoprotein (LDL) particles, together with low levels of HDL
particles, are important risk factors leading to the development of
Figure 4. HDL prevent the deleterious effect of oxLDL particles
on INS-1E cells survival and Cx36 expression. INS-1E cells were
cultured for 48 h in presence or absence (Vh for Vehicule) of 2 mM
nLDL or (oxLDL, in presence or not of 0.5 mM HDL. (A) Apoptosis levels
were evaluated by HO-PI staining. (B) upper panel. Representative
Western Blot anti-Cx36 and tubulin. Lower panel: quantitative assess-
ment of four independent WB. A–B) Data are means 6 SEM of four
independent experiments. ***P,0.001 vs. control. #P,0.05; ##P,0.01
HDL-treated cells vs. oxLDL-treated cells.
doi:10.1371/journal.pone.0055198.g004
Figure 5. nLDL but not oxLDL particles are converted in lipid
droplets in INS-1E cells. (A) Oil Red O staining of INS-1E cells cultured
for 24 h in presence or absence (Vh for Vehicule) of 2 mM nLDL or
oxLDL particles (black bar = 10 mm). Arrows point to lipid droplets. (B)
Quantitative assessment of Plin1 (black bars) and ACC1 (white bars)
over L27 mRNA expression in INS-1E cells cultured for 48 h in presence
of 2 mM nLDL or oxLDL particles. *P,0.05, **P,0.01 vs. Vh condition.
$P,0.05, vs. nLDL condition.
doi:10.1371/journal.pone.0055198.g005
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T2D and the metabolic syndrome [9,10,11,12,13]. The purpose of
this study was to evaluate the impact of prolonged exposure to
high levels of LDL-cholesterol on Cx36 expression since low Cx36
levels have been associated with reduced b-cell function and
survival [3,7]. The characterization of the ApoE2/2 mice, which
display drastically increased levels of circulating cholesterol
[22,23,29,39], revealed that high plasma LDL concentrations
are associated with increased levels of ICER-1, and concomitant
decreased levels of Cx36 in pancreatic islets. Using purified human
LDL particles, we found that oxidized LDL (oxLDL) particles
specifically drive the overexpression of the repressor ICER-1/
ICER-1c, which in turn binds to the Cx36 promoter, leading to
down-regulation of Cx36 transcripts and protein expression levels.
We also show that oxLDL particles are more toxic than native
LDL (nLDL) particles because defective storage and metabolism.
We further demonstrate that Cx36 overexpression partially
protects b-cells against oxLDL-induced apoptosis.
We previously showed that mice fed a high fat diet express
increased levels of ICER-1 and reduced levels of Cx36 [4]. These
mice had elevated levels of circulating FFA, but they were also
slightly hyperglycemic and hypercholesterolemic (total cholesterol)
[4]. Here, we evaluated specifically the effect of cholesterol on
Cx36 expression. The four months-old ApoE2/2 mice used for
this study had typically increased levels of circulating total
cholesterol and no change in glycemia [40]. These mice also
displayed slightly increased circulating levels of FFA (2 fold), and
we cannot exclude that these FFAs contribute to Cx36 down-
regulation in ApoE2/2 mice as previously shown upon
a prolonged high fat diet [4]. Despite the dramatic hypercholes-
terolemia, ICER-1 and Cx36 expression were not considerably
Figure 6. nLDL but not oxLDL particles are b-oxidized in INS-1E cells. (A, G) INS-1E cells were cultured for 48 h in presence of 2 mM nLDL or
oxLDL particles, together or not with etomoxir (50 mM), NAC (1 mM) or myriocin (100 nM). Apoptosis levels were evaluated by HO-PI staining. (B–C)
INS-1E cells were cultured for 48 h in presence of 2 mM nLDL or oxLDL particles, together or not with NAC (1 mM), HDL (1 mM), etomoxir
(Eto:50 mM). As a positive control, cells were treated for 30 min with piocyanin (Pio:200 mM). Data are means6 SEM of five live cells measurements of
ROS/RNS (B) and superoxide O2
2 (C) production. (D–I) INS-1E cells were cultured for 48 h in presence of 2 mM nLDL or oxLDL particles, together or
not with etomoxir (50 mM) or myriocin (100 nM). RT-PCR analysis of SOD1 (D), ICER-1 (E, H) and Cx36 (F, I). *P,0.05, **P,0.01, ***P,0.001 vs. Vh
condition. $P,0.05, $$P,0.01 vs. nLDL condition. #P,0.05; ##P,0.01 vs. respective condition without etomoxir, NAC, HDL or myriocin.
doi:10.1371/journal.pone.0055198.g006
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changed in those mice. This is in accordance with our in vitro data
showing that normal LDL particles are not deleterious to Cx36
expression in b-cells. Of note, Cx36 protein levels as assessed in situ
by immunostaining were far more decreased in ApoE2/2
animals compared to WT than at the mRNA level. This suggests
that either Cx36 protein is further destabilized in ApoE2/2 or
reveals a biased assessment of Cx36 mRNA expression in freshly
isolated islets due to the many artifacts (exposure to RNase,
reducing agents, non linear RNA loss during islet and mRNA
isolation…) and sampling bias (less than 1/3 of the existing islets
Figure 7. Cx36 overexpression protects INS-1E cells against oxLDL-induced apoptosis. (A–C) INS-1E cells were transfected with a control
siRNA (siCtrl) or two different Cx36 siRNA (siCx36#1 and #2). (A) Upper panel: representative Western blot of Cx36 over tubulin expression. Lower
panel: data are means 6 SEM of 4 independent experiments. (B) Prevalence of apoptosis was evaluated by HO-PI staining after 48 h of exposure to
2 mM nLDL or oxLDL particles. (C) ROS/RNS production was evaluated in live cells after 48 h of exposure to 2 mM nLDL or oxLDL particles. (B–C) Data
are means 6 SEM of five experiments. *P,0.05, **P,0.01, ***P,0.001 vs. Vh condition. #P,0.05 ##P,0.01 vs. siCtrl-transfected condition. (D) Islets
from WT (+/+) or Cx36 KO (2/2) mice were exposed for 72 h to 2 mM nLDL or oxLDL particles. Islets viability was evaluated by HO-PI staining. Data
are aligned dot plots of individual islet viability values from five animals per group (+/+ or 2/2) and two separated LDL preparations. Horizontal bars
show mean value 6 SEM. n.s. (non-significant), *P,0.05 vs respective WT values (x2 tests; see table S1). (E) INS-1E cells were infected or not (NI) with
a control adenovirus (Ad-GFP) or a rat Cx36 adenovirus (Ad-Cx36) at various multiplicity of infection (MOI) as indicated. Cells were then exposed or
not (Vh for Vehicule) for 48 h to 2 mM native (nLDL) or oxidized LDL (oxLDL). Upper panel: Representative WB of Cx36 over tubulin expression after
infection. Lower panel: prevalence of apoptosis was evaluated by HO-PI staining. Data are mean 6 SEM of at least 4 independent experiments.
*P,0.05, **P,0.01, ***P,0.001 vs. respective Vh and nLDL conditions. #P,0.05, ##P,0.01 vs. respective non-infected and Ad-GFP-infected
conditions.
doi:10.1371/journal.pone.0055198.g007
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can be isolated in mice as per the most efficient isolation
procedures) which hinder analysis of gene expression from isolated
islets.
The ApoE2/2 mice have raised concerns owning to the very
high ‘‘non-physiological’’ plasma cholesterol levels and the
‘‘quality’’ of lipoproteins [41,42], as cholesterol is carried mostly
in large VLDL and chylomicron remnants [40], whereas pro-
atherogenic particles are thought to be mostly small-dense
oxidized/glycated LDL particles [9,43]. Yet, the ApoE2/2 mice
have been extensively used to study atherosclerotic lesions because
they rapidly develop large plaque throughout the length of the
arterial tree [40,41,42], suggesting that a significant fraction of the
circulating lipoprotein have atherogenic properties. In addition,
and in contrast with the ApoE2/2 mice originally described [44],
our ApoE2/2 mice also had increased circulating levels of HDL
particles, which have been shown to protect against the deleterious
effects of oxLDL particles [18,45,46,47,48]. Altogether those
limitations may account for the seemingly little impact of
hypercholesterolemia on ICER-1 and Cx36 expression in vivo.
This study demonstrates that normal human LDL particles have
no deleterious effects on b-cell survival whereas oxidized LDL
particles have pro-apoptotic effects at fairly physiological concen-
tration (2 mM), supporting the hypothesis that oxLDL particles
greatly contribute to b-cell dysfunction and death in the
pathophysiology of T2D. This is particularly important as small
dense modified LDL particles are early markers of T2D
[11,14,15]. The mechanisms responsible for the detrimental
impact of oxLDL particles on b-cell function and survival are
still poorly understood. The fact that saturated FFA and oxLDL
both induce ICER-1 overexpression [4,19] and Cx36 down-
regulation ([4] and this study) strongly suggest that a similar
mechanism is responsible for the effects of the lipids in both forms.
The deleterious impact of saturated FFAs such as palmitate is due
to accumulation of fatty AcylCoA entering non-oxidative toxic
pathways of fatty acids metabolism, such as de novo ceramide
formation which trigger oxidative stress in the mitochondria [38].
Our data indicate that nLDL particles stimulate lipid b-oxidation
as assessed through Acc1 overexpression. On the other hand,
oxLDL particles had only a marginal impact on ACC1 expression.
Blocking lipid metabolism using the CPT1 inhibitor etomoxir [49]
rendered native LDL particles toxic and aggravated the pro-
apoptotic impact of oxLDL. Conversely, the serine palmitoyl-
transferase inhibitor myriocin, which blocks the synthesis of
ceramide, partially prevented oxLDL-induced apoptosis, ICER-1
overexpression and Cx36 downregulation, suggesting that cer-
amide production is instrumental in oxLDL-induced apoptosis.
Altogether those data suggest that the toxic effect of oxLDL may
partly be due to a defect in metabolism, leading to oxidative stress,
ICER-1 overexpression, Cx36 down-regulation and apoptosis. Oil
red O staining data also revealed that both nLDL and oxLDL
particles lead to the formation of lipid droplets in b-cells. However,
nLDL formed abundant big regular round shaped lipid droplets
whereas oxLDL formed fewer and smaller lipid droplets,
suggesting that oxLDL are not as well stored in the form of lipid
droplets as nLDL in b-cells. These observations are confirmed at
the molecular levels by lower levels of the known marker of lipid
droplets Plin1 [50] in cell exposed to oxLDL as compared to
nLDL particles. Altogether these data suggest that nLDL are not
toxic at this concentration (2 mM) because they are partly b-
oxidized and partly stored in the form of neutral harmless lipid
droplets. On the other hand, oxLDL particles are toxic due to
both defective storage and b-oxidation, which may both result in
accumulation of toxic lipid metabolites such as ceramides
generating oxidative stress both in the form of ROS/RNS and
superoxide anions, similarly to what has been shown with
palmitate [49,51].
Our oxidation protocol leads to the formation of mildly oxidized
LDL [18,19]. Therefore the oxLDL preparation probably still
contains partially oxidized or native nLDL particles. Whether
oxLDL particles themselves or nLDL particles remaining in the
oxLDL preparation are responsible for the intermediate effect of
oxLDL on b-oxidation or lipid droplets formation remains to be
determined.
Our data indicate that oxLDL stimulate the production of
ROS/RNS and superoxide species. ROS/RNS production can be
averted by the antioxidant N-Acetyl cysteine (NAC), whereas
superoxide production is not prevented. NAC partially protected
cells against oxLDL toxicity, indicating that the ROS/RNS
species are involved in oxLDL-induced apoptosis. We previously
demonstrated that oxLDL-induced oxidative stress leads to ICER-
1 overexpression [19]. Furthermore, blocking ICER-1 over-
expression using a siRNA strategy protects b-cell against
oxLDL-induced apoptosis [19]. However the exact mechanisms
underlying the pro-apoptotic impact of ICER-1 is poorly un-
derstood. We recently showed that Cx36 protects mice against b-
cell apoptosis induced by streptozotocin or alloxan, two models of
induced Type1 Diabetes (T1D) [7]. Here, we observed that Cx36
knock-down or knock-out sensitized b-cells to oxLDL particles and
that Cx36 overexpression partially protected b-cells from oxLDL-
induced apoptosis. We further show that Cx36 knock-down
aggravated the production of ROS/RNS, but not superoxide
species, suggesting that Cx36 is able to alleviate (‘‘dilute’’) the
oxidative stress upon oxLDL exposure. Thus intercellular com-
munication may provide protection against pro-apoptotic stresses
involved in the pathophysiology of T2D. Together with our
previous studies showing that prolonged exposure to glucose and/
or saturated FFA lead to ICER-1 overexpression and Cx36 down-
regulation in b-cells [4,8], this study underscores the importance of
this particular mechanism in the pathophysiology of T2D. We
further demonstrated that HDL counteracts the effect of oxLDL
on Cx36 expression. This is in accordance with our previous
finding that HDL particles prevent oxLDL-induced ICER-1
overexpression [19] and other studies showing that HDL particles
are potent antioxidants with strong anti-apoptotic properties in
a variety of models [18,45,46,47,48].
Further studies are required to identify other ICER-1 target
genes with anti-apoptotic properties in b-cells. Given the
prominent role of Cx36 mediated intercellular communication
in b-cell function [6] and survival [7], we suggest that oxLDL-
induced Cx36 down-regulation contributes to oxidative stress
induced upon prolonged exposure to oxLDL, which is involved in
b-cells dysfunction and apoptosis.
Supporting Information
Figure S1 Cx36 immunolabeling is decreased in the
pancreatic islets of APOE2/2mice. A) Cx36 immunolabel-
ing and DAPI staining of WT and APOE2/2 pancreas sections.
Upper panels: black and white Cx36 signal provided by specific
antibodies is seen as white spots all along the membrane of most
islet cells. Lower panels: merged Cx36 (green) and DAPI (blue)
staining. I: islet; E:exocrine tissue. The islet border is outlined by
a dotted white line. Bars: 40 mm. B) Quantitative assessment of
Cx36 immunostaining in WT and ApoE2/2 mice. Data are
mean 6 SEM of 20 to 30 images from 2 distinct experiments and
three animals in each group. *** p,0.001 in ApoE2/2 vs WT
mice.
(TIF)
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Table S1 Statistic table showing the ranking of the
viability values obtained for the experiments showed in
Figure 7D and used to perform statistical analysis.
(DOCX)
Methods S1 Cx36 immunostaining, image processing
and quantification.
(DOCX)
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